Literature DB >> 25338488

Prompt resolution of hypoglycemia by hepatic transarterial embolization for malignant insulinoma with multiple liver metastases.

Shinichiro Muro1, Junichiro Nasu, Ryo Harada, Minoru Matsubara, Asuka Nakarai, Hiromitsu Kanzaki, Kouichiro Tsutsumi, Hironari Kato, Takehiro Tanaka, Hiroyasu Fujiwara, Masatoshi Uno, Hiroyuki Okada, Kazuhide Yamamoto.   

Abstract

A 45-year-old female who presented with loss of consciousness and a cold sweat was found to have a pancreatic tumor and multiple liver metastases. Laboratory studies showed marked hypoglycemia and inappropriately elevated serum insulin, C-peptide, and serum tumor markers. Fine needle aspiration revealed Grade 3 small-cell type primary pancreatic neuroendocrine carcinoma. Consequently, the diagnosis of malignant insulinoma was made. Transarterial embolization (TAE) for hepatic metastases resulted in the reduction of tumor volume and prompt resolution of hypoglycemic attacks, whereas diazoxide and systemic chemotherapy had been ineffective for controlling blood glucose levels, and octreotide was unavailable due to the allergic effect. This case report highlights the potential usefulness of TAE for malignant insulinomas in the management of hypoglycemia.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25338488     DOI: 10.18926/AMO/52900

Source DB:  PubMed          Journal:  Acta Med Okayama        ISSN: 0386-300X            Impact factor:   0.892


  2 in total

Review 1.  Treatment of symptomatic neuroendocrine tumor syndromes: recent advances and controversies.

Authors:  Tetsuhide Ito; Lingaku Lee; Robert T Jensen
Journal:  Expert Opin Pharmacother       Date:  2016-09-23       Impact factor: 3.889

2.  Continuous Hypodynamic Change of Cerebrospinal Fluid Flow as A Potential Factor Working for Experimental Scoliotic Formation.

Authors:  Zhi Zhao; Tao Li; Ni Bi; Zhiyue Shi; Ying Zhang; Quan Li; Yingsong Wang; Jingming Xie
Journal:  Sci Rep       Date:  2020-04-22       Impact factor: 4.379

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.